Kanazawa
Japan
AI system; screening of NAFLD; stage of liver fibrosis in NASH
uric acid, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, xanthine oxidase, oxidative stress, inflammation
Nonalcoholic fatty liver disease, sodium-glucose cotransporter 2 inhibitors, sulfonylureas, liver histologic scores, hepatic expression of the genes